Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...

The news keeps getting better for the new GLP-1 weight-loss drugs fromEli Lilly and Novo Nordisk.

Juanita Gantt told CBS News she was found unconscious on the floor last October ... emergency prompted her to file a lawsuit against Novo Nordisk, the pharmaceutical company that makes Wegovy ...

intensifying the company’s race with Novo Nordisk to develop longer-acting insulins. Lilly’s once-weekly insulin, efsitora alfa, reduced the A1C measure of blood sugar comparably to daily ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Novo Nordisk. Looking at options history for Novo Nordisk NVO we detected 9 trades. If we consider the specifics of ...

The GLP-1 (or glucagon-like peptide-1) drugs are both produced by pharmaceutical giant Novo Nordisk. Gantt said she ... found her unconscious on the floor in October 2023. Doctors discovered ...

Because of her diabetes risk, her doctor agreed she was a good candidate and prescribed her Wegovy and later Ozempic, both GLP-1 drugs made by Novo Nordisk ... her on the floor unconscious.

All dos­es of No­vo Nordisk’s Ozem­pic are ex­pect­ed to face “in­ter­mit­tent short­ages” in Eu­rope dur­ing the fourth quar­ter of the year, es­pe­cial­ly low­er dos­es, ...

Update: Adds company statement about Ozempic availability in the U.S. Novo Nordisk (NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes drug ...

Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. Still ...

Walker adds, ‘Hammer down the tack strips into place, and if nails can’t be used in the space for whatever reason, then you can glue tack strips to the floor carefully, so as not to cover up HVAC ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are big pharma peers. They're also each other's biggest rivals, especially in the all-important market for weight-loss drugs, in which both are ...